The cost-effectiveness of HIV prevention from a managed care perspective.
This article offers a preliminary examination of the intersection of managed care, HIV prevention, and economic considerations. After introducing a basic framework for evaluating the cost-effectiveness of HIV prevention interventions, it reviews the cost-effectiveness literature. The article also examines how the concerns of managed care organizations impact the cost-effectiveness of HIV prevention efforts, including counseling and HIV antibody testing, small group cognitive-behavioral interventions, and community-level interventions. The article closes with a discussion of non-financial incentives for promoting HIV prevention within a managed care framework.
Pinkerton
S D
SD
Center for AIDS Intervention Research, Medical College of Wisconsin, Milwaukee, USA.
Holtgrave
D R
DR
D003362:Cost-Benefit Analysis; D005260:Female; D015658:HIV Infections / Q000191:economics / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008329:Managed Care Programs / Q000191:economics*; D011314:Preventive Health Services / Q000191:economics*; D014481:United States